Evaluation of symmetric dimethylarginine and creatinine in dogs with primary hypoadrenocorticism receiving long-term mineralocorticoid replacement therapy.
Jose I Casado DíazNadja S Sieber-RuckstuhlFelicitas S BorettiFederico FracassiClaudia E ReuschPublished in: The Veterinary record (2021)
Based on these data, the prevalence of CKD could be higher in dogs with PH receiving long-term mineralocorticoid replacement treatment than in the general dog population. However, additional studies with a larger number of dogs are needed to confirm it.